Female Sexual Function After Surgery for Benign Perianal Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-70
SponsorGazi University
About this trial
Benign perianal diseases such as chronic anal fissure, hemorrhoidal disease, and cryptoglandular anal fistula may negatively affect female sexual function through pain, bleeding, discharge, discomfort, and impairment in quality of life. Although improvement in male sexual function after surgery for benign anorectal disorders has been reported, data regarding female sexual function remain limited.
This prospective observational cohort study aims to evaluate changes in Female Sexual Function Index (FSFI) scores following surgical treatment of benign perianal diseases. Female patients undergoing surgery for chronic anal fissure, hemorrhoidal disease, or cryptoglandular anal fistula will be assessed preoperatively and at postoperative 3 and 6 months using the FSFI, Cleveland Clinic Incontinence Score (CCIS/Wexner), and Visual Analog Scale (VAS).
The primary objective is to determine whether female sexual function improves following surgical treatment. Secondary objectives include evaluating the relationship between symptom improvement, continence status, pain reduction, and changes in female sexual function.
Eligibility criteria
Qualifiers
Female patients aged 18-70 years
Sexually active during the previous 4 weeks
Diagnosed with chronic anal fissure, hemorrhoidal disease, or cryptoglandular anal fistula
Scheduled for surgical treatment according to routine clinical indications
Disqualifiers
Inflammatory bowel disease (Crohn's disease or ulcerative colitis)
Pregnancy
Postpartum period within the previous 12 months
Pelvic organ prolapse
Trial design
Treatments tested in this trial
- Surgical Treatment for Benign Perianal Diseases
Treatment groups
120 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov